Vestcor Inc Novavax Inc Transaction History

Vestcor Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $62,220 - $129,122	-1,715 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $18,338 - $37,582	263 Added 18.11%	1,715 $126,000
Q4 2021 Feb 15, 2022	BUY	$134.56 - $217.97 $55,304 - $89,585	411 Added 39.48%	1,452 $208,000
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $24,180 - $36,798	-136 Reduced 11.55%	1,041 $216,000
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $142,417 - $303,277	1,177 New	1,177 $250,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

Stay updated on Vestcor Inc with notifications on news.